Skip to main content

Animations

MJFF Publications

5461 - 5470 of 6420 Results
Title
Year
  • Year
  • 2025
  • 2023
  • 2013
  • 2020
  • 2017
  • 2025
  • 2019
  • 2025
  • 2019
  • 2024
  • Summary Details
    OPEN
    Title: The LRRK2 p.L1795F variant causes Parkinson’s disease in the European population
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-025-00896-2
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Quantitative Benefit-Risk Assessment in Medical Product Decision Making: A Good Practices Report of an ISPOR Task Force
    Journal Name: Value in Health
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: other-oa
    DOI - Digital Object Identifier: 10.1016/j.jval.2022.12.006
    Citation Count: 19
  • Summary Details
    OPEN
    Title: Parkinson's Disease Biomarkers: Resources for Discovery and Validation
    Journal Name: Neuropsychopharmacology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1038/npp.2013.246
    Citation Count: 6
  • Summary Details
    OPEN
    Title: 4319 Team Science in Parkinson’s Research: Connecting Clinicians and Computational Teams
    Journal Name: Journal of Clinical and Translational Science
    Publisher: Cambridge University Press (CUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1017/cts.2020.359
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Evaluating community health workers' attributes, roles, and pathways of action in immigrant communities
    Journal Name: Preventive Medicine
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.ypmed.2017.07.020
    Citation Count: 41
  • Summary Details
    OPEN
    Title: Lysosomal proteomics reveals mechanisms of neuronal APOE4-associated lysosomal dysfunction
    Journal Name: Autophagy
    Publisher: Informa UK Limited
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1080/15548627.2025.2576613
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Generation of Alpha-Synuclein Preformed Fibrils from Monomers and Use In Vivo
    Journal Name: Journal of Visualized Experiments
    Publisher: MyJove Corporation
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.3791/59758
    Citation Count: 43
  • Summary Details
    OPEN
    Title: Long read sequencing reveals transgene concatemerization and vector sequences integration following AAV-driven electroporation of CRISPR RNP complexes in mouse zygotes
    Journal Name: Frontiers in Genome Editing
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fgeed.2025.1582097
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Machine learning for comprehensive forecasting of Alzheimer’s Disease progression
    Journal Name: Scientific Reports
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41598-019-49656-2
    Citation Count: 173
  • Summary Details
    OPEN
    Title: Fox Insight at 5 years - a cohort of 54,000 participants contributing longitudinal patient-reported outcome, genetic, and microbiome data relating to Parkinson’s disease
    Journal Name: Scientific Data
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41597-024-03407-9
    Citation Count: 5
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.